Monoclonal Gammopathy of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Monoclonal Gammopathy of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy [Phase 2]
A Phase 2 clinical trial investigating zanubrutinib for IgM monoclonal gammopathy with anti-MAG-related polyneuropathy is currently recruiti…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
This clinical trial update describes evaluating MALDI-TOF mass spectrometry for screening and monitoring treatment response in multiple myel…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Whole Body MRI in Oncology
This clinical trial update describes a study evaluating whole-body MRI in oncology across multiple cancer types, currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Intestinal Flora and Immunity in Monoclonal Gammopathy Patients
An ongoing clinical trial from Zhujiang Hospital is evaluating whether gut microbiota modulates immune responses in patients with monoclonal…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma [NA]
A completed clinical trial update examining whether dysregulated glutamine metabolism contributes to the pathogenesis of multiple myeloma. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myelom…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Screening for Monoclonal Gammopathy in Individuals Undergoing Physical Examinations Using iMS-LC Assay Technology.
A clinical trial update describes a screening study using iMS-LC assay technology to detect monoclonal gammopathy and M-protein during physi…
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
This clinical trial update describes the S0120 study that collects blood and bone marrow samples from patients with monoclonal gammopathy of…